Leader peptide or pro-segment mutants of renin are misrouted to mitochondria in autosomal dominant tubulointerstitial kidney disease.

Autosomal dominant tubulointerstitial kidney disease Mitochondria Renin Signal sequence Trafficking defect

Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 31 10 2022
accepted: 26 04 2023
aheadofprint: 09 05 2023
medline: 8 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Autosomal dominant tubulointerstitial kidney disease (ADTKD), a rare genetic disorder characterised by progressive chronic kidney disease, is caused by mutations in different genes, including REN, encoding renin. Renin is a secreted protease composed of three domains: the leader peptide that allows insertion in the endoplasmic reticulum (ER), a pro-segment regulating its activity, and the mature part of the protein. Mutations in mature renin lead to ER retention of the mutant protein and to late-onset disease, whereas mutations in the leader peptide, associated with defective ER translocation, and mutations in the pro-segment, leading to accumulation in the ER-to-Golgi compartment, lead to a more severe, early-onset disease. In this study, we demonstrate a common, unprecedented effect of mutations in the leader peptide and pro-segment as they lead to full or partial mistargeting of the mutated proteins to mitochondria. The mutated pre-pro-sequence of renin is necessary and sufficient to drive mitochondrial rerouting, mitochondrial import defect and fragmentation. Mitochondrial localisation and fragmentation were also observed for wild-type renin when ER translocation was affected. These results expand the spectrum of cellular phenotypes associated with ADTKD-associated REN mutations, providing new insight into the molecular pathogenesis of the disease.

Identifiants

pubmed: 37283036
pii: 316587
doi: 10.1242/dmm.049963
pmc: PMC10259838
pii:
doi:

Substances chimiques

Renin EC 3.4.23.15
Protein Sorting Signals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Life Sci Alliance. 2022 Jan 21;5(4):
pubmed: 35064074
Kidney Int. 2020 Dec;98(6):1397-1400
pubmed: 33276865
Cell Rep. 2016 May 17;15(7):1423-1429
pubmed: 27160910
Adv Chronic Kidney Dis. 2017 Mar;24(2):86-93
pubmed: 28284384
Nat Cell Biol. 2018 Jul;20(7):755-765
pubmed: 29950571
Kidney Int. 2010 Mar;77(5):400-6
pubmed: 19924102
N Engl J Med. 2019 Jan 10;380(2):142-151
pubmed: 30586318
Am J Hum Genet. 2009 Aug;85(2):204-13
pubmed: 19664745
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Biol Chem. 2001 Mar 16;276(11):7992-7
pubmed: 11115494
Nat Genet. 2005 Sep;37(9):964-8
pubmed: 16116425
Kidney Int. 2020 Dec;98(6):1589-1604
pubmed: 32750457
Sci Rep. 2019 Aug 12;9(1):11601
pubmed: 31406136
Science. 2018 Feb 9;359(6376):689-692
pubmed: 29348368
Physiol Rev. 2006 Jul;86(3):747-803
pubmed: 16816138
Sci Transl Med. 2016 Jun 8;8(342):342ra78
pubmed: 27280685
Diabetologia. 2020 Oct;63(10):1981-1989
pubmed: 32894308
Nephrol Dial Transplant. 2023 Feb 13;38(2):271-282
pubmed: 34519781
Compr Physiol. 2014 Jul;4(3):1201-28
pubmed: 24944035
Pediatr Nephrol. 2020 Jun;35(6):1125-1128
pubmed: 32198635
J Biol Chem. 2013 Jan 25;288(4):2475-84
pubmed: 23229545
Am J Physiol. 1996 Jul;271(1 Pt 2):F94-100
pubmed: 8760248
Dig Dis Sci. 2017 Jul;62(7):1692-1701
pubmed: 28536777
Nat Rev Dis Primers. 2019 Sep 5;5(1):60
pubmed: 31488840
Clin Nephrol. 2010 Dec;74(6):411-22
pubmed: 21084044
EMBO J. 2013 Apr 3;32(7):1036-51
pubmed: 23481258
Cell Death Dis. 2018 Nov 7;9(11):1122
pubmed: 30405116
Front Endocrinol (Lausanne). 2022 Jan 05;12:774634
pubmed: 35069438
J Am Chem Soc. 2019 May 29;141(21):8450-8461
pubmed: 31059257
Sci Rep. 2021 Jun 2;11(1):11562
pubmed: 34079010
Mol Aspects Med. 2015 Apr;42:3-18
pubmed: 25542748
Sci Rep. 2017 Feb 21;7:42970
pubmed: 28220896

Auteurs

Céline Schaeffer (C)

IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Vita-Salute San Raffaele University, 20132 Milan, Italy.

Maurizio De Fusco (M)

IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Elena Pasqualetto (E)

IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Caterina Scolari (C)

IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

Claudia Izzi (C)

Division of Nephrology and Dialysis, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia and ASST-Spedali Civili of Brescia, 25123 Brescia, Italy.
Medical Genetics Clinic, Department of Obstetrics and Gynaecology, ASST Spedali Civili, 25123 Brescia, Italy.

Francesco Scolari (F)

Division of Nephrology and Dialysis, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia and ASST-Spedali Civili of Brescia, 25123 Brescia, Italy.

Luca Rampoldi (L)

IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Vita-Salute San Raffaele University, 20132 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH